<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11770071</article-id><article-id pub-id-type="pmcid-ver">PMC11770071.1</article-id><article-id pub-id-type="pmcaid">11770071</article-id><article-id pub-id-type="pmcaiid">11770071</article-id><article-id pub-id-type="pmid">39865071</article-id><article-id pub-id-type="doi">10.1038/s41598-025-85559-1</article-id><article-id pub-id-type="publisher-id">85559</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Development and validation of a prognostic nomogram for predicting of patients with acute sedative-hypnotic overdose admitted to the intensive care unit</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Tang</surname><given-names initials="G">Guo</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="T">Tianshan</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="P">Ping</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="S">Sha</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cheng</surname><given-names initials="T">Tao</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Yao</surname><given-names initials="R">Rong</given-names></name><address><email>yaorong@wchscu.cn</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/011ashp19</institution-id><institution-id institution-id-type="GRID">grid.13291.38</institution-id><institution-id institution-id-type="ISNI">0000 0001 0807 1581</institution-id><institution>Emergency Medicine Laboratory and the Department of Emergency, West China Hospital, </institution><institution>Sichuan University, </institution></institution-wrap>No. 37 Guoxue Alley, Chengdu, 610041 Sichuan China </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">478255</issue-id><elocation-id>3323</elocation-id><history><date date-type="received"><day>13</day><month>8</month><year>2024</year></date><date date-type="accepted"><day>3</day><month>1</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>01</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>27</day><month>01</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-31 13:25:34.260"><day>31</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41598_2025_Article_85559.pdf"/><abstract id="Abs1"><p id="Par1">To develop and evaluate a predictive model for intensive care unit (ICU) admission among patients with acute sedative-hypnotic overdose. We conducted a retrospective analysis of patients admitted to the emergency department of West China Hospital, Sichuan University, between October 11, 2009, and December 31, 2023. Patients were divided into ICU and non-ICU groups based on admission criteria including the need for blood purification therapy, organ support therapy (ventilatory support, vasoactive drugs, renal replacement therapy, artificial liver), or post-cardiopulmonary resuscitation. Patients were randomly split into a training set and a validation set in a 7:3 ratio. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to optimize variables, followed by a multivariate logistic regression analysis to identify independent risk factors for ICU admission. A nomogram model was constructed and assessed using receiver operating characteristic (ROC) curves, calibration curves, Decision Curve Analysis (DCA), and Clinical Impact Curve (CIC). Predictors in the nomogram included barbiturate overdose, Glasgow Coma Scale (GCS) score, and anion gap at admission. The nomogram demonstrated strong predictive performance with an area under the curve (AUC) of 0.858 (95% CI: 0.788&#8211;0.927) in the training set and 0.845 (95% CI: 0.757&#8211;0.933) in the validation set. Calibration curves showed the model closely matched the ideal curve, and DCA and CIC indicated high clinical applicability and utility. Barbiturate overdose, initial decreased GCS score and decreased anion gap were identified as independent risk factors for ICU admission in acute sedative-hypnotic overdose. The nomogram model based on these indicators demonstrates good predictive accuracy, discrimination, and clinical utility.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Acute Sedative-hypnotic overdose</kwd><kwd>Intensive care unit</kwd><kwd>Prognosis</kwd><kwd>Risk factors</kwd><kwd>Nomogram</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Medical research</kwd><kwd>Risk factors</kwd><kwd>Human behaviour</kwd><kwd>Psychiatric disorders</kwd></kwd-group><funding-group><award-group><funding-source><institution>the Peking Union Medical College Medical Foundation - Rui E (Ruiyi) Emergency Medicine Research Special Fund</institution></funding-source><award-id>22322012013</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>Sichuan Provincial Natural Science Foundation Youth Fund Project</institution></funding-source><award-id>23NSFSC4251</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Acute drug overdose is the leading cause of acute poisoning globally and is a common condition encountered in emergency departments. This phenomenon is typically the result of drug overuse or inappropriate medication practices, with sedative-hypnotic overdoses being the most prevalent<sup><xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref></sup>. These substances primarily exert their effects by inhibiting gamma-aminobutyric acid (GABA) receptors in the brain, resulting in a series of complex psychological and physiological responses that often require urgent medical intervention<sup><xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref></sup>. Some patients may suffer severe organ damage or even death<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Reports indicate that the proportion of acute sedative-hypnotic overdoses admitted to intensive care unit (ICU) is the highest among all drug overdoses, ranging from 14.3 to 31.0%, with an in-hospital mortality rate of 1.0&#8211;3.6%<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>. Consequently, early identification of patients with acute sedative-hypnotic overdoses who require ICU admission could potentially enhance their prognosis. However, current clinical research on ICU admissions related to acute sedative-hypnotic overdoses is relatively scarce. This study aims to conduct a retrospective analysis of patients with acute sedative overdoses to identify associated risk factors for ICU admission and to develop a risk prediction model to inform early clinical intervention.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study design</title><p id="Par3">This study was a single-center, retrospective, cross-sectional study aimed at constructing and evaluating a nomogram model for predicting ICU admission in patients with acute sedative-hypnotic overdose, based on the latest predictive model guidelines and artificial intelligence reporting standards<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>.</p></sec><sec id="Sec4"><title>Study population</title><p id="Par4">The study involved patients who presented to the emergency department of West China Hospital, Sichuan University, between October 10, 2009, and December 31, 2023, due to acute sedative-hypnotic overdose. The diagnosis of sedative-hypnotic overdose was established based on a clear history of exposure and corresponding clinical manifestations, including changes in mental status, general weakness, and abdominal pain, while excluding other diseases that present with similar clinical features<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. According to the International Classification of Diseases, 10th Revision (ICD-10), sedative-hypnotics were classified into three categories: barbiturates, benzodiazepines, and Z-drugs<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>.</p><p id="Par5">The inclusion criteria for the study were: (1) age&#8201;&#8805;&#8201;14 years; and (2) onset of symptoms within 72&#160;h. The exclusion criteria included: (1) co-occurrence with other types of poisoning (e.g., alcohol, pesticides); (2) co-occurrence with acute physical or chemical injuries (e.g., burns, trauma); and (3) incomplete clinical information.</p></sec><sec id="Sec5"><title>Variables and grouping</title><p id="Par6">The study variables encompassed general information, including age, sex, the presence of psychiatric disorders along with their specific diagnoses, and the types of drugs ingested. In cases of mixed drug overdose, more than two classes of drugs were involved; if patients or their families reported an overdose of sedative-hypnotic agents but could not specify the exact drug, these were categorized as unspecified drugs. Additional variables included the time from overdose to presentation, as well as clinical signs at presentation such as temperature, heart rate, respiratory rate, peripheral oxygen saturation, systolic and diastolic blood pressure, and Glasgow Coma Scale (GCS) scores. Initial laboratory results measured included hemoglobin, platelet count, white blood cell count, absolute neutrophil count, absolute lymphocyte count, total bilirubin, direct bilirubin, alanine aminotransferase, aspartate aminotransferase, albumin, glucose, urea, creatinine, uric acid, sodium, potassium, chloride, and anion gap. In-hospital treatment interventions included toxic substance removal, administration of specific antidotes, organ support therapy, and cardiopulmonary resuscitation.</p><p id="Par7">Patients were categorized into an ICU admission group and a non-ICU admission group based on their admission status to the ICU during their hospital stay. Indications for ICU admission included the need for blood purification therapy, organ support therapy (such as mechanical ventilation, vasoactive drugs, renal replacement therapy, or artificial liver support), or post-cardiopulmonary resuscitation care. Disease severity, clinical signs at presentation, and initial laboratory results were compared between the two groups.</p><p id="Par8">All patients were monitored until discharge, with the endpoint defined as the discharge status, which was categorized as improved or recovered; not improved or worsened; or deceased.</p></sec><sec id="Sec6"><title>Sample size calculation</title><p id="Par9">The sample size was calculated using the &#8220;pmsampsize&#8221; function to ensure adequate statistical power<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Parameters included a C-index of 0.8, 4 candidate predictors, an overall event rate of 0.14, resulting in a required sample size of 231, with 8.09 events per candidate predictor.</p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par10">Statistical analysis was performed using R 4.4.1 software. Normally distributed continuous variables were presented as mean&#8201;&#177;&#8201;standard deviation (x&#8201;&#177;&#8201;s) and compared between groups using the t-test. Skewed continuous variables were presented as median (interquartile range) and compared using the Mann-Whitney U test. Categorical variables were presented as n (%) and compared using the chi-square test or Fisher&#8217;s exact test.</p><p id="Par11">Patients were randomly divided into training and validation sets in a 7:3 ratio through simple random sampling without replacement. In the training set, the least absolute shrinkage and selection operator (LASSO) regression was employed to optimize variables, thereby mitigating potential multicollinearity and overfitting. The selected variables were subsequently included in a multivariate logistic regression analysis utilizing a forward stepwise method to identify independent risk factors for ICU admission, and a nomogram model was constructed. The model&#8217;s performance was assessed using receiver operating characteristic (ROC) curves, calibration curves, decision curve analysis (DCA), and clinical impact curves (CIC) in both the training and validation sets<sup><xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR21">21</xref></sup>. Internal validation was conducted through bootstrap resampling with 1000 resamples<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Features and grouping</title><p id="Par12">During the study period, a total of 292 patients with acute sedative-hypnotic overdose presented to the emergency department. Based on the established inclusion and exclusion criteria, 284 patients were included in the analysis (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>), of which 225 (80.3%) were female, with an average age of 42.0 years (range: 24.8 to 56.0 years). ICU admission was necessary for 51 (18.0%) of the patients. Compared to the non-ICU group, the ICU group exhibited a higher prevalence of a history of mental illness (66.7% vs. 48.5%, <italic toggle="yes">P</italic>&#8201;=&#8201;0.028), a greater proportion of barbiturate use (9.8% vs. 1.29%, <italic toggle="yes">P</italic>&#8201;=&#8201;0.006), higher white blood cell counts (7.54&#8201;&#215;&#8201;10&#8313;/L vs. 6.58&#8201;&#215;&#8201;10&#8313;/L, <italic toggle="yes">P</italic>&#8201;=&#8201;0.002), absolute neutrophil counts (5.76&#8201;&#215;&#8201;10&#8313;/L vs. 4.41&#8201;&#215;&#8201;10&#8313;/L, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001), and glucose levels (5.99 mmol/L vs. 5.44 mmol/L, <italic toggle="yes">P</italic>&#8201;=&#8201;0.001). Conversely, the ICU group demonstrated lower GCS scores (3 vs. 15, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001), hemoglobin levels (118&#160;g/L vs. 128&#160;g/L, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001), absolute lymphocyte counts (1.31&#8201;&#215;&#8201;10&#8313;/L vs. 1.53&#8201;&#215;&#8201;10&#8313;/L, <italic toggle="yes">P</italic>&#8201;=&#8201;0.013), direct bilirubin levels (2.50 &#181;mol/L vs. 3.40 &#181;mol/L, <italic toggle="yes">P</italic>&#8201;=&#8201;0.034), albumin levels (40.4&#160;g/L vs. 42.5&#160;g/L, <italic toggle="yes">P</italic>&#8201;=&#8201;0.003), and anion gap values (11.1 &#181;mol/L vs. 15.2 &#181;mol/L, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). Patients were randomly divided into training (198 patients) and validation (86 patients) sets in a 7:3 ratio. In the training set, 158 (79.8%) were female, with an average age of 37 years (25 to 56 years), and ICU admission was required for 30 (15.2%) patients. In the validation set, 67 (77.9%) were female, with an average age of 40.0 years (range: 24.0 to 54.5 years), and ICU admission was required for 21 (24.4%) patients. No statistically significant differences were found between the training and validation sets (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).</p><p id="Par13">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Flowchart of the study.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e318" position="float" orientation="portrait" xlink:href="41598_2025_85559_Fig1_HTML.jpg"/></fig>
</p><p id="Par14">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Comparison between ICU-admitted and Non-ICU-admitted patients.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Risk factors</th><th align="left" colspan="1" rowspan="1">Non-ICU admission group (<italic toggle="yes">N</italic>&#8201;=&#8201;233)</th><th align="left" colspan="1" rowspan="1">ICU admission group(<italic toggle="yes">N</italic>&#8201;=&#8201;51)</th><th align="left" colspan="1" rowspan="1">
<italic toggle="yes">P</italic>
</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Sex (female)</td><td align="left" colspan="1" rowspan="1">181 (77.7%)</td><td align="left" colspan="1" rowspan="1">44 (86.3%)</td><td align="left" colspan="1" rowspan="1">0.238</td></tr><tr><td align="left" colspan="1" rowspan="1">Age (years)</td><td align="left" colspan="1" rowspan="1">37.0 [25.0;53.0]</td><td align="left" colspan="1" rowspan="1">46.0 [22.5;69.0]</td><td align="left" colspan="1" rowspan="1">0.184</td></tr><tr><td align="left" colspan="1" rowspan="1">Time from poisoning to treatment at the study site (h)</td><td align="left" colspan="1" rowspan="1">3.00 [2.00;10.0]</td><td align="left" colspan="1" rowspan="1">5.00 [2.00;14.0]</td><td align="left" colspan="1" rowspan="1">0.093</td></tr><tr><td align="left" colspan="1" rowspan="1">Presence of psychiatric history(%)</td><td align="left" colspan="1" rowspan="1">113 (48.5%)</td><td align="left" colspan="1" rowspan="1">34 (66.7%)</td><td align="left" colspan="1" rowspan="1">0.028</td></tr><tr><td align="left" colspan="1" rowspan="1">Depression(%)</td><td align="left" colspan="1" rowspan="1">74 (31.8%)</td><td align="left" colspan="1" rowspan="1">22 (43.1%)</td><td align="left" colspan="1" rowspan="1">0.164</td></tr><tr><td align="left" colspan="1" rowspan="1">Bipolar Disorder(%)</td><td align="left" colspan="1" rowspan="1">11 (4.72%)</td><td align="left" colspan="1" rowspan="1">5 (9.80%)</td><td align="left" colspan="1" rowspan="1">0.177</td></tr><tr><td align="left" colspan="1" rowspan="1">Schizophrenia(%)</td><td align="left" colspan="1" rowspan="1">6 (2.58%)</td><td align="left" colspan="1" rowspan="1">3 (5.88%)</td><td align="left" colspan="1" rowspan="1">0.207</td></tr><tr><td align="left" colspan="1" rowspan="1">Anxiety(%)</td><td align="left" colspan="1" rowspan="1">6 (2.58%)</td><td align="left" colspan="1" rowspan="1">2 (3.92%)</td><td align="left" colspan="1" rowspan="1">0.638</td></tr><tr><td align="left" colspan="1" rowspan="1">Other Psychiatric Disorders(%)</td><td align="left" colspan="1" rowspan="1">20 (8.58%)</td><td align="left" colspan="1" rowspan="1">3 (5.88%)</td><td align="left" colspan="1" rowspan="1">0.777</td></tr><tr><td align="left" colspan="4" rowspan="1">Types of overdose</td></tr><tr><td align="left" colspan="1" rowspan="1">Benzodiazepines(%)</td><td align="left" colspan="1" rowspan="1">176 (75.5%)</td><td align="left" colspan="1" rowspan="1">43 (84.3%)</td><td align="left" colspan="1" rowspan="1">0.243</td></tr><tr><td align="left" colspan="1" rowspan="1">Barbiturates(%)</td><td align="left" colspan="1" rowspan="1">3 (1.29%)</td><td align="left" colspan="1" rowspan="1">5 (9.80%)</td><td align="left" colspan="1" rowspan="1">0.006</td></tr><tr><td align="left" colspan="1" rowspan="1">Z-Drugs(%)</td><td align="left" colspan="1" rowspan="1">19 (8.15%)</td><td align="left" colspan="1" rowspan="1">1 (1.96%)</td><td align="left" colspan="1" rowspan="1">0.141</td></tr><tr><td align="left" colspan="1" rowspan="1">Unknown(%)</td><td align="left" colspan="1" rowspan="1">3 (1.29%)</td><td align="left" colspan="1" rowspan="1">0 (0.00%)</td><td align="left" colspan="1" rowspan="1">1.000</td></tr><tr><td align="left" colspan="1" rowspan="1">Polydrug Overdose(%)</td><td align="left" colspan="1" rowspan="1">32 (13.7%)</td><td align="left" colspan="1" rowspan="1">2 (3.92%)</td><td align="left" colspan="1" rowspan="1">0.086</td></tr><tr><td align="left" colspan="4" rowspan="1">Clinical signs at presentation laboratory</td></tr><tr><td align="left" colspan="1" rowspan="1">Temperature(&#8451;)</td><td align="left" colspan="1" rowspan="1">36.5 [36.3;36.7]</td><td align="left" colspan="1" rowspan="1">36.5 [36.2;36.7]</td><td align="left" colspan="1" rowspan="1">0.948</td></tr><tr><td align="left" colspan="1" rowspan="1">Heart Rate (beat/min)</td><td align="left" colspan="1" rowspan="1">85.0 [73.0;97.0]</td><td align="left" colspan="1" rowspan="1">87.0 [73.5;99.0]</td><td align="left" colspan="1" rowspan="1">0.371</td></tr><tr><td align="left" colspan="1" rowspan="1">Respiratory Rate (beats/min)</td><td align="left" colspan="1" rowspan="1">20.0 [19.0;20.0]</td><td align="left" colspan="1" rowspan="1">20.0 [18.5;20.5]</td><td align="left" colspan="1" rowspan="1">0.859</td></tr><tr><td align="left" colspan="1" rowspan="1">Systolic blood pressure(mmHg)</td><td align="left" colspan="1" rowspan="1">115 [103;126]</td><td align="left" colspan="1" rowspan="1">112 [102;126]</td><td align="left" colspan="1" rowspan="1">0.679</td></tr><tr><td align="left" colspan="1" rowspan="1">Diastolic blood pressure(mmHg)</td><td align="left" colspan="1" rowspan="1">72.0 [65.0;80.0]</td><td align="left" colspan="1" rowspan="1">71.0 [64.5;80.5]</td><td align="left" colspan="1" rowspan="1">0.571</td></tr><tr><td align="left" colspan="1" rowspan="1">Peripheral Oxygen Saturation(%)</td><td align="left" colspan="1" rowspan="1">97.0 [96.0;99.0]</td><td align="left" colspan="1" rowspan="1">97.0 [96.0;98.0]</td><td align="left" colspan="1" rowspan="1">0.889</td></tr><tr><td align="left" colspan="1" rowspan="1">Glasgow Coma Scale</td><td align="left" colspan="1" rowspan="1">15.0 [11.0;15.0]</td><td align="left" colspan="1" rowspan="1">3.00 [3.00;11.5]</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="4" rowspan="1">Results at presentation</td></tr><tr><td align="left" colspan="1" rowspan="1">Hemoglobin(g/L)</td><td align="left" colspan="1" rowspan="1">128 [120;137]</td><td align="left" colspan="1" rowspan="1">118 [109;128]</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Platelet Count(&#215;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">197 [154;238]</td><td align="left" colspan="1" rowspan="1">207 [150;244]</td><td align="left" colspan="1" rowspan="1">0.772</td></tr><tr><td align="left" colspan="1" rowspan="1">White Blood Cell Count (&#215;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">6.58 [5.34;8.06]</td><td align="left" colspan="1" rowspan="1">7.54 [6.42;10.3]</td><td align="left" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1">Absolute Neutrophil Count (10^9/L)</td><td align="left" colspan="1" rowspan="1">4.41 [3.16;6.00]</td><td align="left" colspan="1" rowspan="1">5.76 [4.39;8.19]</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Absolute Lymphocyte Count (10^9/L)</td><td align="left" colspan="1" rowspan="1">1.53 [1.19;1.92]</td><td align="left" colspan="1" rowspan="1">1.31 [0.86;1.70]</td><td align="left" colspan="1" rowspan="1">0.013</td></tr><tr><td align="left" colspan="1" rowspan="1">Total Bilirubin(&#181;mol/l)</td><td align="left" colspan="1" rowspan="1">10.3 [7.40;13.6]</td><td align="left" colspan="1" rowspan="1">8.60 [6.00;13.3]</td><td align="left" colspan="1" rowspan="1">0.155</td></tr><tr><td align="left" colspan="1" rowspan="1">Direct Bilirubin(&#181;mol/l)</td><td align="left" colspan="1" rowspan="1">3.40 [2.30;4.70]</td><td align="left" colspan="1" rowspan="1">2.50 [1.80;4.30]</td><td align="left" colspan="1" rowspan="1">0.034</td></tr><tr><td align="left" colspan="1" rowspan="1">Alanine Aminotransferase (IU/L)</td><td align="left" colspan="1" rowspan="1">14.0 [10.0;22.0]</td><td align="left" colspan="1" rowspan="1">13.0 [8.50;19.5]</td><td align="left" colspan="1" rowspan="1">0.177</td></tr><tr><td align="left" colspan="1" rowspan="1">Aminotransferase (IU/L)</td><td align="left" colspan="1" rowspan="1">19.0 [15.0;26.0]</td><td align="left" colspan="1" rowspan="1">17.0 [14.0;24.5]</td><td align="left" colspan="1" rowspan="1">0.572</td></tr><tr><td align="left" colspan="1" rowspan="1">Albumin (g/L)</td><td align="left" colspan="1" rowspan="1">42.5 [40.2;44.8]</td><td align="left" colspan="1" rowspan="1">40.4 [37.7;43.3]</td><td align="left" colspan="1" rowspan="1">0.003</td></tr><tr><td align="left" colspan="1" rowspan="1">Glucose(mmol/L)</td><td align="left" colspan="1" rowspan="1">5.44 [4.83;6.10]</td><td align="left" colspan="1" rowspan="1">5.99 [5.39;7.54]</td><td align="left" colspan="1" rowspan="1">0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood Urea Nitrogen (mmol/L)</td><td align="left" colspan="1" rowspan="1">4.20 [3.30;5.31]</td><td align="left" colspan="1" rowspan="1">3.70 [3.02;4.75]</td><td align="left" colspan="1" rowspan="1">0.139</td></tr><tr><td align="left" colspan="1" rowspan="1">Serum Creatinine(&#181;mol/L)</td><td align="left" colspan="1" rowspan="1">61.0 [52.0;71.0]</td><td align="left" colspan="1" rowspan="1">60.0 [54.0;67.5]</td><td align="left" colspan="1" rowspan="1">0.791</td></tr><tr><td align="left" colspan="1" rowspan="1">Uric Acid(mmol/L)</td><td align="left" colspan="1" rowspan="1">286 [228;345]</td><td align="left" colspan="1" rowspan="1">274 [196;338]</td><td align="left" colspan="1" rowspan="1">0.162</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood Sodium (mmol/L)</td><td align="left" colspan="1" rowspan="1">139 [137;141]</td><td align="left" colspan="1" rowspan="1">138 [136;139]</td><td align="left" colspan="1" rowspan="1">0.063</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood Potassium (mmol/L)</td><td align="left" colspan="1" rowspan="1">3.59 [3.35;3.78]</td><td align="left" colspan="1" rowspan="1">3.51 [3.21;3.76]</td><td align="left" colspan="1" rowspan="1">0.156</td></tr><tr><td align="left" colspan="1" rowspan="1">Chloride (mmol/L)</td><td align="left" colspan="1" rowspan="1">104 [102;107]</td><td align="left" colspan="1" rowspan="1">104 [102;107]</td><td align="left" colspan="1" rowspan="1">0.513</td></tr><tr><td align="left" colspan="1" rowspan="1">Anion Gap(umol/L)</td><td align="left" colspan="1" rowspan="1">15.2 [11.9;17.7]</td><td align="left" colspan="1" rowspan="1">11.1 [8.25;15.4]</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Clinical outcomes</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Cured (%)</td><td align="left" colspan="1" rowspan="1">232 (99.6%)</td><td align="left" colspan="1" rowspan="1">44 (86.3%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Failure to recover or automatic discharge (%)</td><td align="left" colspan="1" rowspan="1">1 (0.43%)</td><td align="left" colspan="1" rowspan="1">6 (11.8%)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Deaths (%)</td><td align="left" colspan="1" rowspan="1">0 (0.00%)</td><td align="left" colspan="1" rowspan="1">1 (1.96%)</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table></table-wrap>
</p><p id="Par15">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Comparison of baseline characteristics between the training and validation sets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Risk factors</th><th align="left" colspan="1" rowspan="1">Training set (<italic toggle="yes">N</italic>&#8201;=&#8201;198)</th><th align="left" colspan="1" rowspan="1">Validation set (<italic toggle="yes">N</italic>&#8201;=&#8201;86)</th><th align="left" colspan="1" rowspan="1">
<italic toggle="yes">P</italic>
</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Sex (female)</td><td align="left" colspan="1" rowspan="1">158 (79.8%)</td><td align="left" colspan="1" rowspan="1">67 (77.9%)</td><td align="left" colspan="1" rowspan="1">0.840</td></tr><tr><td align="left" colspan="1" rowspan="1">Age (years)</td><td align="left" colspan="1" rowspan="1">37.0 [25.0;56.0]</td><td align="left" colspan="1" rowspan="1">40.0 [24.0;54.5]</td><td align="left" colspan="1" rowspan="1">0.706</td></tr><tr><td align="left" colspan="1" rowspan="1">Time from poisoning to treatment at the study site (h)</td><td align="left" colspan="1" rowspan="1">3.00 [2.00;10.0]</td><td align="left" colspan="1" rowspan="1">4.00 [2.00;10.8]</td><td align="left" colspan="1" rowspan="1">0.235</td></tr><tr><td align="left" colspan="1" rowspan="1">Presence of psychiatric history (%)</td><td align="left" colspan="1" rowspan="1">104 (52.5%)</td><td align="left" colspan="1" rowspan="1">43 (50.0%)</td><td align="left" colspan="1" rowspan="1">0.793</td></tr><tr><td align="left" colspan="1" rowspan="1">Depression (%)</td><td align="left" colspan="1" rowspan="1">71 (35.9%)</td><td align="left" colspan="1" rowspan="1">25 (29.1%)</td><td align="left" colspan="1" rowspan="1">0.330</td></tr><tr><td align="left" colspan="1" rowspan="1">Bipolar disorder (%)</td><td align="left" colspan="1" rowspan="1">10 (5.05%)</td><td align="left" colspan="1" rowspan="1">6 (6.98%)</td><td align="left" colspan="1" rowspan="1">0.578</td></tr><tr><td align="left" colspan="1" rowspan="1">Schizophrenia (%)</td><td align="left" colspan="1" rowspan="1">5 (2.53%)</td><td align="left" colspan="1" rowspan="1">4 (4.65%)</td><td align="left" colspan="1" rowspan="1">0.461</td></tr><tr><td align="left" colspan="1" rowspan="1">Anxiety (%)</td><td align="left" colspan="1" rowspan="1">4 (2.02%)</td><td align="left" colspan="1" rowspan="1">4 (4.65%)</td><td align="left" colspan="1" rowspan="1">0.250</td></tr><tr><td align="left" colspan="1" rowspan="1">Other psychiatric disorders (%)</td><td align="left" colspan="1" rowspan="1">17 (8.59%)</td><td align="left" colspan="1" rowspan="1">6 (6.98%)</td><td align="left" colspan="1" rowspan="1">0.826</td></tr><tr><td align="left" colspan="4" rowspan="1">Types of overdose</td></tr><tr><td align="left" colspan="1" rowspan="1">Benzodiazepines (%)</td><td align="left" colspan="1" rowspan="1">154 (77.8%)</td><td align="left" colspan="1" rowspan="1">65 (75.6%)</td><td align="left" colspan="1" rowspan="1">0.802</td></tr><tr><td align="left" colspan="1" rowspan="1">Barbiturates (%)</td><td align="left" colspan="1" rowspan="1">6 (3.03%)</td><td align="left" colspan="1" rowspan="1">2 (2.33%)</td><td align="left" colspan="1" rowspan="1">1.000</td></tr><tr><td align="left" colspan="1" rowspan="1">Z-Drugs (%)</td><td align="left" colspan="1" rowspan="1">11 (5.56%)</td><td align="left" colspan="1" rowspan="1">9 (10.5%)</td><td align="left" colspan="1" rowspan="1">0.217</td></tr><tr><td align="left" colspan="1" rowspan="1">Unknown (%)</td><td align="left" colspan="1" rowspan="1">25 (12.6%)</td><td align="left" colspan="1" rowspan="1">9 (10.5%)</td><td align="left" colspan="1" rowspan="1">0.752</td></tr><tr><td align="left" colspan="1" rowspan="1">Polydrug overdose (%)</td><td align="left" colspan="1" rowspan="1">2 (1.01%)</td><td align="left" colspan="1" rowspan="1">1 (1.16%)</td><td align="left" colspan="1" rowspan="1">1.000</td></tr><tr><td align="left" colspan="4" rowspan="1">Clinical signs at presentation laboratory</td></tr><tr><td align="left" colspan="1" rowspan="1">Temperature (&#8451;)</td><td align="left" colspan="1" rowspan="1">36.5 [36.2;36.7]</td><td align="left" colspan="1" rowspan="1">36.5 [36.3;36.7]</td><td align="left" colspan="1" rowspan="1">0.598</td></tr><tr><td align="left" colspan="1" rowspan="1">Heart Rate (beat/min)</td><td align="left" colspan="1" rowspan="1">85.0 [73.0;97.0]</td><td align="left" colspan="1" rowspan="1">85.0 [72.2;96.0]</td><td align="left" colspan="1" rowspan="1">0.875</td></tr><tr><td align="left" colspan="1" rowspan="1">Respiratory rate (beats/min)</td><td align="left" colspan="1" rowspan="1">20.0 [19.0;20.0]</td><td align="left" colspan="1" rowspan="1">20.0 [19.0;21.0]</td><td align="left" colspan="1" rowspan="1">0.318</td></tr><tr><td align="left" colspan="1" rowspan="1">Systolic blood pressure (mmHg)</td><td align="left" colspan="1" rowspan="1">115 [103;127]</td><td align="left" colspan="1" rowspan="1">113 [103;125]</td><td align="left" colspan="1" rowspan="1">0.747</td></tr><tr><td align="left" colspan="1" rowspan="1">Diastolic blood pressure (mmHg)</td><td align="left" colspan="1" rowspan="1">72.0 [66.0;80.0]</td><td align="left" colspan="1" rowspan="1">70.5 [64.2;79.0]</td><td align="left" colspan="1" rowspan="1">0.179</td></tr><tr><td align="left" colspan="1" rowspan="1">Peripheral oxygen saturation (%)</td><td align="left" colspan="1" rowspan="1">97.0 [95.2;98.0]</td><td align="left" colspan="1" rowspan="1">97.0 [96.0;98.0]</td><td align="left" colspan="1" rowspan="1">0.722</td></tr><tr><td align="left" colspan="1" rowspan="1">Glasgow coma scale</td><td align="left" colspan="1" rowspan="1">14.0 [9.00;15.0]</td><td align="left" colspan="1" rowspan="1">15.0 [5.75;15.0]</td><td align="left" colspan="1" rowspan="1">0.862</td></tr><tr><td align="left" colspan="4" rowspan="1">Results at presentation</td></tr><tr><td align="left" colspan="1" rowspan="1">Hemoglobin (g/L)</td><td align="left" colspan="1" rowspan="1">127 [118;136]</td><td align="left" colspan="1" rowspan="1">126 [116;136]</td><td align="left" colspan="1" rowspan="1">0.739</td></tr><tr><td align="left" colspan="1" rowspan="1">Platelet count (&#215;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">196 [154;243]</td><td align="left" colspan="1" rowspan="1">202 [150;234]</td><td align="left" colspan="1" rowspan="1">0.998</td></tr><tr><td align="left" colspan="1" rowspan="1">White blood cell count (&#215;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">6.64 [5.39;8.53]</td><td align="left" colspan="1" rowspan="1">6.96 [5.82;8.33]</td><td align="left" colspan="1" rowspan="1">0.541</td></tr><tr><td align="left" colspan="1" rowspan="1">Absolute neutrophil count (&#215;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">4.54 [3.24;6.31]</td><td align="left" colspan="1" rowspan="1">4.77 [3.46;6.27]</td><td align="left" colspan="1" rowspan="1">0.652</td></tr><tr><td align="left" colspan="1" rowspan="1">Absolute lymphocyte count (&#215;10<sup>9</sup>/L)</td><td align="left" colspan="1" rowspan="1">1.48 [1.10;1.89]</td><td align="left" colspan="1" rowspan="1">1.52 [1.09;1.90]</td><td align="left" colspan="1" rowspan="1">0.848</td></tr><tr><td align="left" colspan="1" rowspan="1">Total bilirubin (&#181;mol/l)</td><td align="left" colspan="1" rowspan="1">10.4 [6.93;13.6]</td><td align="left" colspan="1" rowspan="1">9.00 [6.82;13.4]</td><td align="left" colspan="1" rowspan="1">0.687</td></tr><tr><td align="left" colspan="1" rowspan="1">Direct bilirubin (&#181;mol/l)</td><td align="left" colspan="1" rowspan="1">3.30 [2.02;4.50]</td><td align="left" colspan="1" rowspan="1">3.30 [2.30;4.77]</td><td align="left" colspan="1" rowspan="1">0.664</td></tr><tr><td align="left" colspan="1" rowspan="1">Alanine aminotransferase (IU/L)</td><td align="left" colspan="1" rowspan="1">14.0 [10.0;22.0]</td><td align="left" colspan="1" rowspan="1">14.0 [9.25;20.0]</td><td align="left" colspan="1" rowspan="1">0.752</td></tr><tr><td align="left" colspan="1" rowspan="1">Aminotransferase (IU/L)</td><td align="left" colspan="1" rowspan="1">19.0 [15.0;26.0]</td><td align="left" colspan="1" rowspan="1">17.5 [15.0;22.0]</td><td align="left" colspan="1" rowspan="1">0.332</td></tr><tr><td align="left" colspan="1" rowspan="1">Albumin (g/L)</td><td align="left" colspan="1" rowspan="1">42.3 [39.7;44.5]</td><td align="left" colspan="1" rowspan="1">42.0 [39.5;44.8]</td><td align="left" colspan="1" rowspan="1">0.767</td></tr><tr><td align="left" colspan="1" rowspan="1">Glucose (mmol/L)</td><td align="left" colspan="1" rowspan="1">5.55 [5.04;6.50]</td><td align="left" colspan="1" rowspan="1">5.14 [4.80;6.10]</td><td align="left" colspan="1" rowspan="1">0.027</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood urea nitrogen (mmol/L)</td><td align="left" colspan="1" rowspan="1">4.20 [3.20;5.27]</td><td align="left" colspan="1" rowspan="1">4.02 [3.24;5.07]</td><td align="left" colspan="1" rowspan="1">0.987</td></tr><tr><td align="left" colspan="1" rowspan="1">Serum creatinine (&#181;mol/L)</td><td align="left" colspan="1" rowspan="1">61.0 [52.0;70.0]</td><td align="left" colspan="1" rowspan="1">60.0 [52.0;69.8]</td><td align="left" colspan="1" rowspan="1">0.542</td></tr><tr><td align="left" colspan="1" rowspan="1">Uric acid (mmol/L)</td><td align="left" colspan="1" rowspan="1">286 [222;342]</td><td align="left" colspan="1" rowspan="1">276 [211;364]</td><td align="left" colspan="1" rowspan="1">0.783</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood sodium (mmol/L)</td><td align="left" colspan="1" rowspan="1">139 [137;140]</td><td align="left" colspan="1" rowspan="1">139 [137;141]</td><td align="left" colspan="1" rowspan="1">0.275</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood potassium (mmol/L)</td><td align="left" colspan="1" rowspan="1">3.59 [3.37;3.78]</td><td align="left" colspan="1" rowspan="1">3.56 [3.26;3.79]</td><td align="left" colspan="1" rowspan="1">0.406</td></tr><tr><td align="left" colspan="1" rowspan="1">Chloride (mmol/L)</td><td align="left" colspan="1" rowspan="1">104 [102;107]</td><td align="left" colspan="1" rowspan="1">104 [102;106]</td><td align="left" colspan="1" rowspan="1">0.680</td></tr><tr><td align="left" colspan="1" rowspan="1">Anion Gap (umol/L)</td><td align="left" colspan="1" rowspan="1">14.6 [10.9;17.7]</td><td align="left" colspan="1" rowspan="1">15.2 [12.5;17.4]</td><td align="left" colspan="1" rowspan="1">0.341</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec10"><title>Construction of the nomogram model</title><p id="Par16">In this study, demographic and clinical data from 198 patients with sedative-hypnotic overdose were analyzed. The &#8220;glmnet&#8221; package was utilized to perform LASSO regression, which facilitated the selection of feature variables (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). This analysis identified three significant variables: the presence of barbiturate overdose, the GCS score at presentation, and the anion gap. These variables were subsequently incorporated into a multivariate logistic regression analysis using a forward stepwise method to ascertain independent risk factors. The results indicated that barbiturate overdose (OR: 111.62, 95% CI: 9.09-1370.5), a decreased GCS score at presentation (OR: 0.79, 95% CI: 0.71&#8211;0.87), and a reduced anion gap (OR: 0.84, 95% CI: 0.75&#8211;0.94) were independent predictors of ICU admission (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>). Additionally, a nomogram was constructed based on these three indicators (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>), where each predictor was assigned a point on the nomogram, and the total score corresponded to the probability of ICU admission, displayed at the bottom.</p><p id="Par17">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>LASSO regression was used for demographic and clinical feature selection. (A) LASSO regression cross-validation results; (B) LASSO regression coefficient log (Lambda) profile.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1189" position="float" orientation="portrait" xlink:href="41598_2025_85559_Fig2_HTML.jpg"/></fig>
</p><p id="Par18">
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Risk factors of patients with acute sedative-hypnotic drug overdose admitted to ICU.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variable</th><th align="left" colspan="1" rowspan="1">Crude OR (95% CI)</th><th align="left" colspan="1" rowspan="1">Adjusted OR (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic>(Wald&#8217;s test)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic>(LR test)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Barbiturates</td><td char="." align="char" colspan="1" rowspan="1">33.4(3.75,297.78)</td><td char="." align="char" colspan="1" rowspan="1">111.62(9.09,1370.5)</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Glasgow Coma Scale</td><td char="." align="char" colspan="1" rowspan="1">0.81 (0.75,0.89)</td><td char="." align="char" colspan="1" rowspan="1">0.79 (0.71,0.87)</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Anion Gap</td><td char="." align="char" colspan="1" rowspan="1">0.87 (0.8,0.96)</td><td char="." align="char" colspan="1" rowspan="1">0.84 (0.75,0.94)</td><td char="." align="char" colspan="1" rowspan="1">0.002</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr></tbody></table></table-wrap>
</p><p id="Par19">
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Nomogram model of patients with acute sedative-hypnotic drug overdose admitted to ICU.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1265" position="float" orientation="portrait" xlink:href="41598_2025_85559_Fig3_HTML.jpg"/></fig>
</p></sec><sec id="Sec11"><title>Evaluation of the nomogram model</title><p id="Par20">To evaluate the performance of the predictive model, we plotted ROC curves, calibration curves, DCA curves, and CIC curves for both the training and validation sets. Figure&#160;<xref rid="Fig4" ref-type="fig">4</xref>(A) and 4(B) present the ROC curves for these sets, demonstrating that the model achieved an AUC of 0.858 (95% CI: 0.788&#8211;0.927) in the training set and 0.845 (95% CI: 0.757&#8211;0.933) in the validation set. Furthermore, the calibration curves illustrated strong consistency between predicted and observed outcomes in both sets (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>A and B). The DCA curves revealed a significant net benefit of the predictive model (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>A and B), while the CIC curves indicated substantial clinical utility with thresholds exceeding 0.4 in both sets (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>A, B).</p><p id="Par21">
<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>(<bold>A</bold>) ROC curve of the nomogram in the training set; (<bold>B</bold>) ROC curves of the nomogram in the validation set. Notes: ROC: Receiver Operating Characteristic Curve; AUC: area under the curve.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1298" position="float" orientation="portrait" xlink:href="41598_2025_85559_Fig4_HTML.jpg"/></fig>
</p><p id="Par22">
<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><p>(<bold>A</bold>) Calibration curve of the nomogram in the training set; (<bold>B</bold>) Calibration curves of the nomogram in the validation set.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1315" position="float" orientation="portrait" xlink:href="41598_2025_85559_Fig5_HTML.jpg"/></fig>
</p><p id="Par23">
<fig id="Fig6" position="float" orientation="portrait"><label>Fig. 6</label><caption><p>(<bold>A</bold>) Decision curve analysis of the nomogram in the training set; (<bold>B</bold>) Decision curve analysis of the nomogram in the validation set.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1332" position="float" orientation="portrait" xlink:href="41598_2025_85559_Fig6_HTML.jpg"/></fig>
</p><p id="Par24">
<fig id="Fig7" position="float" orientation="portrait"><label>Fig. 7</label><caption><p>(<bold>A</bold>) Clinical Impact Curve of the nomogram in the training set; (<bold>B</bold>) Clinical Impact Curve of the nomogram in the validation set.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1349" position="float" orientation="portrait" xlink:href="41598_2025_85559_Fig7_HTML.jpg"/></fig>
</p></sec></sec><sec id="Sec12"><title>Discussion</title><p id="Par25">Sedative-hypnotic overdose represents an increasingly serious public health concern. Patients frequently present with transient disturbances in consciousness; while most individuals show improvement with prompt treatment, a subset may progress to severe illness, resulting in significant organ damage or even death<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. This study found that approximately 18% of patients required admission to the ICU. Previous studies have demonstrated significant variability in the probability of drug overdose patients requiring ICU admission, with rates ranging from 1.3&#8211;36.4%<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR23">23</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref></sup>. Cioccari et al. analyzed 18,050 drug overdose cases and reported an ICU admission rate of 1.3%<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. In contrast, Sharif et al. studied 143 patients poisoned by substances with central nervous system toxicity and found an ICU admission rate of 36.4%<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. This discrepancy may be attributed to differences in the types of drugs involved and variations in ICU admission criteria. In this study, patients admitted to the ICU demonstrated significantly lower recovery rates and higher in-hospital mortality rates compared to their non-ICU counterparts. Consequently, a prompt and accurate assessment of disease severity is essential for formulating appropriate treatment plans and enhancing patient outcomes. However, there is currently a deficiency of specific tools for evaluating the severity of acute sedative-hypnotic overdose in emergency settings. Through clinical data analysis, this study identified three independent risk factors for ICU admission in patients with acute sedative-hypnotic overdose: the presence of barbiturate overdose, a decreased GCS score and anion gap at presentation. A nomogram model was constructed incorporating these factors, demonstrating strong predictive performance with an area under the curve (AUC) of 0.858 (95% CI: 0.788&#8211;0.927) in the training set and an AUC of 0.845 (95% CI: 0.757&#8211;0.933) in the validation set. The model exhibited good clinical applicability and practicality, as indicated by calibration curves, DCA curves, and CIC. Since these indicators are readily obtainable shortly after patient presentation, the model is feasible for emergency application and dissemination, potentially providing clinicians with more accurate early assessments of disease severity and prognosis.</p><p id="Par26">This study identifies a decreased GCS score at presentation as a risk factor for ICU admission in patients experiencing acute sedative-hypnotic overdose. Altered consciousness is a prevalent characteristic of drug overdose<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. The underlying mechanisms may involve the effects of these substances on various neurotransmitter receptors within the brain. Existing research indicates that GABA receptors are the primary targets for benzodiazepines and barbiturates, which enhance GABAergic transmission and produce a pharmacological effect<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. GABA receptors serve as the main inhibitory neurotransmitter receptors in the central nervous system, regulating chloride ion channels, activating G proteins, causing cell hyperpolarization, slowing impulse transmission, or inhibiting adenylate cyclase activity, thereby resulting in an overall inhibitory effect<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR33">33</xref>&#8211;<xref ref-type="bibr" rid="CR36">36</xref></sup>. Changes in the level of consciousness are associated with the dosage or type of ingested drugs, which can increase the risk of complications such as respiratory depression and aspiration, making it a valuable indicator of the severity of antipsychotic overdose. Additionally, our study identifies the anion gap as an independent risk factor for ICU admission in patients with acute sedative-hypnotic overdose, consistent with previous reports<sup><xref ref-type="bibr" rid="CR37">37</xref>&#8211;<xref ref-type="bibr" rid="CR40">40</xref></sup>. The anion gap is a laboratory measurement that reflects the difference between serum cations and anions, indicating the concentration of unmeasured anions. In cases of metabolic acidosis caused by the accumulation of strong acids, such as lactate or beta-hydroxybutyrate in extracellular fluid, bicarbonate levels decrease while the anion gap increases. The extent of the anion gap elevation correlates with the plasma concentration of these accumulated anions. Potential causes of an increased anion gap include ingestion of ethylene glycol, acetaminophen, methanol, aspirin, renal failure, or ketoacidosis<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Furthermore, existing literature suggests that a reduction in the anion gap may indicate the presence of electrolyte metabolism disorders or hypoalbuminemia in the patient<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. In patients with acute sedative-hypnotic overdose, decreased anion gaps may be the result of homeostatic imbalance related to multiple mechanisms<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>.</p><p id="Par27">Barbiturate overdose constitutes an independent risk factor for ICU admission in patients experiencing acute sedative-hypnotic overdose. Research on phenobarbital overdose is limited, primarily consisting of case reports<sup><xref ref-type="bibr" rid="CR43">43</xref>&#8211;<xref ref-type="bibr" rid="CR45">45</xref></sup>. Satoshi et al. conducted a retrospective study involving 277 patients who presented with drug overdoses at a hospital in Tokyo from 2011 to 2012<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. They found that barbiturate overdose is an independent risk factor for the development of aspiration pneumonia and the need for endotracheal intubation. Existing literature indicates that barbiturates predominantly impact the central nervous system, potentially leading to shallow breathing and coma in severe cases<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. The concomitant use of barbiturates with other central nervous system depressants, such as benzodiazepines, exacerbates the depressant effects on both the central nervous and respiratory systems, making overdose particularly hazardous<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Therefore, recognizing barbiturate use in cases of sedative-hypnotic overdose is crucial for facilitating early intervention and treatment. In patients with acute sedative-hypnotic overdose, a decreased anion gap may arise from homeostatic imbalances related to multiple mechanisms.</p><p id="Par28">Few studies have focused on ICU admissions related to sedative-hypnotic overdose. Lu et al. conducted a retrospective analysis of 140 cases of acute benzodiazepine overdose in patients aged 18 and older, treated in the emergency department of Taipei Veterans General Hospital between 2012 and 2015<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Their findings revealed that 97 patients (69.2%) required hospitalization, 20 patients (14.3%) were admitted to the ICU, and 3 patients (2.1%) succumbed to their condition. Multivariate analysis identified concomitant pneumonia and the administration of flumazenil in the emergency department as independent risk factors for ICU admission. However, the study&#8217;s small sample size limited its findings, and it did not develop a nomogram model for clinical prediction. Additionally, research on ICU admissions for barbiturate and Z-drug overdoses is limited, highlighting the need for further investigation in this area.</p><p id="Par29">This study has several limitations. Firstly, it was a single-center, retrospective investigation that exclusively included clinical data obtained at the time of hospital admission, without follow-up on post-discharge survival, which may influence the results. Moreover, the vital signs recorded during visit were manually measured by medical staff, potentially leading some inaccuracies. Prospective studies are necessary to assess the long-term prognostic significance of these indicators and to implement follow-up monitoring of high-risk populations. Additionally, due to limitations in sample size, external validation of the predictive model was not conducted, highlighting the need for further evaluation of the model&#8217;s efficacy. In conclusion, while our research is comprehensive, the results may be influenced by advancements in blood purification treatment technologies, ongoing developments in liver and stomach protective medications, and improvements in antibiotic treatments.</p></sec><sec id="Sec13"><title>Conclusion</title><p id="Par30">This study identified barbiturate overdose, a decreased GCS score at presentation, and a reduced anion gap as independent risk factors for ICU admission in patients experiencing acute sedative-hypnotic overdose. The nomogram model developed from these indicators exhibited strong predictive performance for ICU admission in this patient population.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>NA.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>GT performed all data analysis, wrote the main manuscript text and prepared all figures and table. TSZ, PZ, SY and TC were resposible for the data curation. RY conducted the design and review of the article. All authors reviewed the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the Peking Union Medical College Medical Foundation - Rui E (Ruiyi) Emergency Medicine Research Special Fund (22322012013), Sichuan Provincial Natural Science Foundation Youth Fund Project (23NSFSC4251).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets generated during and/or analyzed during the current study are not publicly available due to data confidentiality. However, they can be obtained from the corresponding author upon reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par31">The authors declare no competing interests.</p></notes><notes id="FPar2"><title>Ethics approval</title><p id="Par32">The West China Hospital approved the study of the Sichuan University Biomedical Research Ethics Committee (No. 2022&#8201;&#8722;&#8201;1458). The requirement to obtain informed consent in this analysis was waived due to the retrospective noninterventional design. All analyses were performed following the Transparent Reporting of a multivariate prediction model for Individual Prognosis or Diagnosis statement. This statement indicates that the study was approved by the Sichuan University Biomedical Research Ethics Committee, and the need for informed consent was waived due to the retrospective nature of the research and the fact that it was a noninterventional study. The research was conducted in compliance with the Transparent Reporting of a multivariate prediction model for Individual Prognosis or Diagnosis guidelines.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beaune</surname><given-names>S</given-names></name><name name-style="western"><surname>Juvin</surname><given-names>P</given-names></name><name name-style="western"><surname>Beauchet</surname><given-names>A</given-names></name><name name-style="western"><surname>Casalino</surname><given-names>E</given-names></name><name name-style="western"><surname>Megarbane</surname><given-names>B</given-names></name></person-group><article-title>Deliberate drug poisonings admitted to an emergency department in Paris area - a descriptive study and assessment of risk factors for intensive care admission</article-title><source>Eur. Rev. Med. Pharmacol. Sci.</source><year>2016</year><volume>20</volume><issue>6</issue><fpage>1174</fpage><lpage>1179</lpage><pub-id pub-id-type="pmid">27049274</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Beaune, S., Juvin, P., Beauchet, A., Casalino, E. &amp; Megarbane, B. Deliberate drug poisonings admitted to an emergency department in Paris area - a descriptive study and assessment of risk factors for intensive care admission. <italic toggle="yes">Eur. Rev. Med. Pharmacol. Sci.</italic><bold>20</bold>(6), 1174&#8211;1179 (2016).<pub-id pub-id-type="pmid">27049274</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Descamps</surname><given-names>AK</given-names></name><name name-style="western"><surname>Vandijck</surname><given-names>DM</given-names></name><name name-style="western"><surname>Buylaert</surname><given-names>WA</given-names></name><name name-style="western"><surname>Mostin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Paepe</surname><given-names>P</given-names></name></person-group><article-title>Characteristics and costs in adults with acute poisoning admitted to the emergency department of a university hospital in Belgium</article-title><source>PLoS One</source><year>2019</year><volume>14</volume><issue>10</issue><fpage>e0223479</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0223479</pub-id><pub-id pub-id-type="pmid">31584988</pub-id><pub-id pub-id-type="pmcid">PMC6777762</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Descamps, A. K., Vandijck, D. M., Buylaert, W. A., Mostin, M. A. &amp; Paepe, P. Characteristics and costs in adults with acute poisoning admitted to the emergency department of a university hospital in Belgium. <italic toggle="yes">PLoS ONE</italic><bold>14</bold>(10), e0223479 (2019).<pub-id pub-id-type="pmid">31584988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0223479</pub-id><pub-id pub-id-type="pmcid">PMC6777762</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daly</surname><given-names>C</given-names></name><etal/></person-group><article-title>Frequently used drug types and alcohol involvement in intentional drug overdoses in Ireland: a national registry study</article-title><source>Eur. J. Public. Health</source><year>2018</year><volume>28</volume><issue>4</issue><fpage>681</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">29538652</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurpub/cky031</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Daly, C. et al. Frequently used drug types and alcohol involvement in intentional drug overdoses in Ireland: a national registry study. <italic toggle="yes">Eur. J. Public. Health</italic><bold>28</bold>(4), 681&#8211;686 (2018).<pub-id pub-id-type="pmid">29538652</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurpub/cky031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ichikura</surname><given-names>K</given-names></name><name name-style="western"><surname>Okumura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>T</given-names></name></person-group><article-title>Associations of adverse clinical course and ingested substances among patients with deliberate drug poisoning: a Cohort Study from an Intensive Care Unit in Japan</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>8</issue><fpage>e0161996</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0161996</pub-id><pub-id pub-id-type="pmid">27560966</pub-id><pub-id pub-id-type="pmcid">PMC4999209</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Ichikura, K., Okumura, Y. &amp; Takeuchi, T. Associations of adverse clinical course and ingested substances among patients with deliberate drug poisoning: a Cohort Study from an Intensive Care Unit in Japan. <italic toggle="yes">PLoS ONE</italic><bold>11</bold>(8), e0161996 (2016).<pub-id pub-id-type="pmid">27560966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0161996</pub-id><pub-id pub-id-type="pmcid">PMC4999209</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tournier</surname><given-names>M</given-names></name><name name-style="western"><surname>Grolleau</surname><given-names>A</given-names></name><name name-style="western"><surname>Cougnard</surname><given-names>A</given-names></name><name name-style="western"><surname>Molimard</surname><given-names>M</given-names></name><name name-style="western"><surname>Verdoux</surname><given-names>H</given-names></name></person-group><article-title>Factors associated with choice of psychotropic drugs used for intentional drug overdose</article-title><source>Eur. Arch. Psychiatry Clin. Neurosci.</source><year>2009</year><volume>259</volume><issue>2</issue><fpage>86</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1007/s00406-008-0839-2</pub-id><pub-id pub-id-type="pmid">18806918</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Tournier, M., Grolleau, A., Cougnard, A., Molimard, M. &amp; Verdoux, H. Factors associated with choice of psychotropic drugs used for intentional drug overdose. <italic toggle="yes">Eur. Arch. Psychiatry Clin. Neurosci.</italic><bold>259</bold>(2), 86&#8211;91 (2009).<pub-id pub-id-type="pmid">18806918</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00406-008-0839-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vancayseele</surname><given-names>N</given-names></name><name name-style="western"><surname>Rotsaert</surname><given-names>I</given-names></name><name name-style="western"><surname>Portzky</surname><given-names>G</given-names></name><name name-style="western"><surname>van Heeringen</surname><given-names>K</given-names></name></person-group><article-title>Medication used in intentional drug overdose in Flanders 2008&#8211;2013</article-title><source>PLoS One</source><year>2019</year><volume>14</volume><issue>5</issue><fpage>e0216317</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0216317</pub-id><pub-id pub-id-type="pmid">31048918</pub-id><pub-id pub-id-type="pmcid">PMC6497282</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Vancayseele, N., Rotsaert, I., Portzky, G. &amp; van Heeringen, K. Medication used in intentional drug overdose in Flanders 2008&#8211;2013. <italic toggle="yes">PLoS ONE</italic><bold>14</bold>(5), e0216317 (2019).<pub-id pub-id-type="pmid">31048918</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0216317</pub-id><pub-id pub-id-type="pmcid">PMC6497282</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kovacic</surname><given-names>V</given-names></name><etal/></person-group><article-title>Clinical and demographic features with outcome predictors of adult patients with acute intoxication admitted to a medical intensive care unit in the Mediterranean part of Croatia</article-title><source>Toxicol. Res. (Camb)</source><year>2023</year><volume>12</volume><issue>4</issue><fpage>626</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1093/toxres/tfad054</pub-id><pub-id pub-id-type="pmid">37663800</pub-id><pub-id pub-id-type="pmcid">PMC10470373</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Kovacic, V. et al. Clinical and demographic features with outcome predictors of adult patients with acute intoxication admitted to a medical intensive care unit in the Mediterranean part of Croatia. <italic toggle="yes">Toxicol. Res. (Camb)</italic><bold>12</bold>(4), 626&#8211;634 (2023).<pub-id pub-id-type="pmid">37663800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxres/tfad054</pub-id><pub-id pub-id-type="pmcid">PMC10470373</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Gummin, D. D. et al. 2020 Annual Report of the American Association of Poison Control Centers&#8217; National Poison Data System (NPDS): 38th Annual Report. <italic toggle="yes">Clin .Toxicol. (Phila)</italic><bold>59</bold>(12), 1282&#8211;1501 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15563650.2021.1989785</pub-id><pub-id pub-id-type="pmid">34890263</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arora</surname><given-names>I</given-names></name><name name-style="western"><surname>Mal</surname><given-names>P</given-names></name><name name-style="western"><surname>Arora</surname><given-names>P</given-names></name><name name-style="western"><surname>Paul</surname><given-names>A</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>M</given-names></name></person-group><article-title>GABAergic implications in anxiety and related disorders</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2024</year><volume>724</volume><fpage>150218</fpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2024.150218</pub-id><pub-id pub-id-type="pmid">38865810</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Arora, I., Mal, P., Arora, P., Paul, A. &amp; Kumar, M. GABAergic implications in anxiety and related disorders. <italic toggle="yes">Biochem. Biophys. Res. Commun.</italic><bold>724</bold>, 150218 (2024).<pub-id pub-id-type="pmid">38865810</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2024.150218</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dionisio</surname><given-names>L</given-names></name><name name-style="western"><surname>De Jos&#233;</surname><given-names>M</given-names></name><name name-style="western"><surname>Bouzat</surname><given-names>C</given-names></name><name name-style="western"><surname>Esandi Mdel</surname><given-names>C</given-names></name></person-group><article-title>An intrinsic GABAergic system in human lymphocytes</article-title><source>Neuropharmacology</source><year>2011</year><volume>60</volume><issue>2&#8211;3</issue><fpage>513</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2010.11.007</pub-id><pub-id pub-id-type="pmid">21093461</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Dionisio, L., De Jos&#233;, M., Bouzat, C. &amp; Esandi Mdel, C. An intrinsic GABAergic system in human lymphocytes. <italic toggle="yes">Neuropharmacology</italic><bold>60</bold>(2&#8211;3), 513&#8211;519 (2011).<pub-id pub-id-type="pmid">21093461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuropharm.2010.11.007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gladkevich</surname><given-names>A</given-names></name><name name-style="western"><surname>Korf</surname><given-names>J</given-names></name><name name-style="western"><surname>Hakobyan</surname><given-names>VP</given-names></name><name name-style="western"><surname>Melkonyan</surname><given-names>KV</given-names></name></person-group><article-title>The peripheral GABAergic system as a target in endocrine disorders</article-title><source>Auton. Neurosci.</source><year>2006</year><volume>124</volume><issue>1&#8211;2</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.autneu.2005.11.002</pub-id><pub-id pub-id-type="pmid">16338174</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Gladkevich, A., Korf, J., Hakobyan, V. P. &amp; Melkonyan, K. V. The peripheral GABAergic system as a target in endocrine disorders. <italic toggle="yes">Auton. Neurosci.</italic><bold>124</bold>(1&#8211;2), 1&#8211;8 (2006).<pub-id pub-id-type="pmid">16338174</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.autneu.2005.11.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Incidence and lethality of suicidal overdoses by Drug Class</article-title><source>JAMA Netw. Open.</source><year>2020</year><volume>3</volume><issue>3</issue><fpage>e200607</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.0607</pub-id><pub-id pub-id-type="pmid">32202643</pub-id><pub-id pub-id-type="pmcid">PMC7090840</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Miller, T. R. et al. Incidence and lethality of suicidal overdoses by drug class. <italic toggle="yes">JAMA Netw. Open.</italic><bold>3</bold>(3), e200607 (2020).<pub-id pub-id-type="pmid">32202643</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2020.0607</pub-id><pub-id pub-id-type="pmcid">PMC7090840</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>CY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CI</given-names></name><name name-style="western"><surname>Huang</surname><given-names>HH</given-names></name><name name-style="western"><surname>Yen</surname><given-names>DH</given-names></name></person-group><article-title>Clinical predictors for Intensive Care Unit Admission in patients with benzodiazepines Poisoning in the Emergency Department</article-title><source>J. Acute Med.</source><year>2018</year><volume>8</volume><issue>4</issue><fpage>168</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">32995219</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.6705/j.jacme.201812_8(4).0004</pub-id><pub-id pub-id-type="pmcid">PMC7517951</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Lu, C. Y., Chang, C. I., Huang, H. H. &amp; Yen, D. H. Clinical predictors for Intensive Care Unit Admission in patients with benzodiazepines Poisoning in the Emergency Department. <italic toggle="yes">J. Acute Med.</italic><bold>8</bold>(4), 168&#8211;178 (2018).<pub-id pub-id-type="pmid">32995219</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.6705/j.jacme.201812_8(4).0004</pub-id><pub-id pub-id-type="pmcid">PMC7517951</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharif</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Prognostic factors in acute poisoning with central nervous system xenobiotics: development of a nomogram predicting risk of intensive care unit admission</article-title><source>Toxicol. Res. (Camb)</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>62</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1093/toxres/tfac084</pub-id><pub-id pub-id-type="pmid">36866212</pub-id><pub-id pub-id-type="pmcid">PMC9972822</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Sharif, A. F. et al. Prognostic factors in acute poisoning with central nervous system xenobiotics: development of a nomogram predicting risk of intensive care unit admission. <italic toggle="yes">Toxicol. Res. (Camb)</italic><bold>12</bold>(1), 62&#8211;75 (2022).<pub-id pub-id-type="pmid">36866212</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxres/tfac084</pub-id><pub-id pub-id-type="pmcid">PMC9972822</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>GS</given-names></name><etal/></person-group><article-title>TRIPOD&#8201;+&#8201;AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods</article-title><source>BMJ</source><year>2024</year><volume>385</volume><fpage>e078378</fpage><pub-id pub-id-type="doi">10.1136/bmj-2023-078378</pub-id><pub-id pub-id-type="pmid">38626948</pub-id><pub-id pub-id-type="pmcid">PMC11019967</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Collins, G. S. et al. TRIPOD&#8201;+&#8201;AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. <italic toggle="yes">BMJ</italic><bold>385</bold>, e078378 (2024).<pub-id pub-id-type="pmid">38626948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj-2023-078378</pub-id><pub-id pub-id-type="pmcid">PMC11019967</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">World Health Organization. <italic toggle="yes">International Statistical Classification of Diseases and Related Health Problems. 10 Revision</italic> 5th edn (WHO Library Cataloguing-in-Publication Data, 2016).</mixed-citation></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riley</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Minimum sample size for external validation of a clinical prediction model with a binary outcome</article-title><source>Stat. Med.</source><year>2021</year><volume>40</volume><issue>19</issue><fpage>4230</fpage><lpage>4251</lpage><pub-id pub-id-type="doi">10.1002/sim.9025</pub-id><pub-id pub-id-type="pmid">34031906</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Riley, R. D. et al. Minimum sample size for external validation of a clinical prediction model with a binary outcome. <italic toggle="yes">Stat. Med.</italic><bold>40</bold>(19), 4230&#8211;4251 (2021).<pub-id pub-id-type="pmid">34031906</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/sim.9025</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riley</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Calculating the sample size required for developing a clinical prediction model</article-title><source>BMJ</source><year>2020</year><volume>368</volume><fpage>m441</fpage><pub-id pub-id-type="doi">10.1136/bmj.m441</pub-id><pub-id pub-id-type="pmid">32188600</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Riley, R. D. et al. Calculating the sample size required for developing a clinical prediction model. <italic toggle="yes">BMJ</italic><bold>368</bold>, m441 (2020).<pub-id pub-id-type="pmid">32188600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.m441</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caetano</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Sonpavde</surname><given-names>G</given-names></name><name name-style="western"><surname>Pond</surname><given-names>GR</given-names></name></person-group><article-title>C-statistic: a brief explanation of its construction, interpretation and limitations</article-title><source>Eur. J. Cancer</source><year>2018</year><volume>90</volume><fpage>130</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2017.10.027</pub-id><pub-id pub-id-type="pmid">29221899</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Caetano, S. J., Sonpavde, G. &amp; Pond, G. R. C-statistic: a brief explanation of its construction, interpretation and limitations. <italic toggle="yes">Eur. J. Cancer</italic>. <bold>90</bold>, 130&#8211;132 (2018).<pub-id pub-id-type="pmid">29221899</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejca.2017.10.027</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alba</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Discrimination and calibration of clinical prediction models: users&#8217; guides to the Medical Literature</article-title><source>JAMA</source><year>2017</year><volume>318</volume><issue>14</issue><fpage>1377</fpage><lpage>1384</lpage><pub-id pub-id-type="doi">10.1001/jama.2017.12126</pub-id><pub-id pub-id-type="pmid">29049590</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Alba, A. C. et al. Discrimination and calibration of clinical prediction models: users&#8217; guides to the Medical Literature. <italic toggle="yes">JAMA</italic><bold>318</bold>(14), 1377&#8211;1384 (2017).<pub-id pub-id-type="pmid">29049590</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2017.12126</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vickers</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Elkin</surname><given-names>EB</given-names></name></person-group><article-title>Decision curve analysis: a novel method for evaluating prediction models</article-title><source>Med. Decis. Mak.</source><year>2006</year><volume>26</volume><issue>6</issue><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1177/0272989X06295361</pub-id><pub-id pub-id-type="pmcid">PMC2577036</pub-id><pub-id pub-id-type="pmid">17099194</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Vickers, A. J. &amp; Elkin, E. B. Decision curve analysis: a novel method for evaluating prediction models. <italic toggle="yes">Med. Decis. Mak.</italic><bold>26</bold>(6), 565&#8211;574 (2006).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0272989X06295361</pub-id><pub-id pub-id-type="pmcid">PMC2577036</pub-id><pub-id pub-id-type="pmid">17099194</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pencina</surname><given-names>MJ</given-names></name><name name-style="western"><surname>D&#8217;Agostino</surname><given-names>RB</given-names></name></person-group><article-title>Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation</article-title><source>Stat. Med.</source><year>2004</year><volume>23</volume><issue>13</issue><fpage>2109</fpage><lpage>2123</lpage><pub-id pub-id-type="doi">10.1002/sim.1802</pub-id><pub-id pub-id-type="pmid">15211606</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Pencina, M. J. &amp; D&#8217;Agostino, R. B. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. <italic toggle="yes">Stat. Med.</italic><bold>23</bold>(13), 2109&#8211;2123 (2004).<pub-id pub-id-type="pmid">15211606</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/sim.1802</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#233;garbane</surname><given-names>B</given-names></name><name name-style="western"><surname>Deye</surname><given-names>N</given-names></name><name name-style="western"><surname>Malissin</surname><given-names>I</given-names></name><name name-style="western"><surname>Baud</surname><given-names>FJ</given-names></name></person-group><article-title>Usefulness of the serum lactate concentration for predicting mortality in acute beta-blocker poisoning</article-title><source>Clin. Toxicol. (Phila)</source><year>2010</year><volume>48</volume><issue>10</issue><fpage>974</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.3109/15563650.2010.534483</pub-id><pub-id pub-id-type="pmid">21192755</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">M&#233;garbane, B., Deye, N., Malissin, I. &amp; Baud, F. J. Usefulness of the serum lactate concentration for predicting mortality in acute beta-blocker poisoning. <italic toggle="yes">Clin. Toxicol. (Phila)</italic><bold>48</bold>(10), 974&#8211;978 (2010).<pub-id pub-id-type="pmid">21192755</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/15563650.2010.534483</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eizadi Mood</surname><given-names>N</given-names></name><name name-style="western"><surname>Sabzghabaee</surname><given-names>AM</given-names></name><name name-style="western"><surname>Khalili-Dehkordi</surname><given-names>Z</given-names></name></person-group><article-title>Applicability of different scoring systems in outcome prediction of patients with mixed drug poisoning-induced coma</article-title><source>Indian J. Anaesth.</source><year>2011</year><volume>55</volume><issue>6</issue><fpage>599</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.4103/0019-5049.90616</pub-id><pub-id pub-id-type="pmid">22223905</pub-id><pub-id pub-id-type="pmcid">PMC3249868</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Eizadi Mood, N., Sabzghabaee, A. M. &amp; Khalili-Dehkordi, Z. Applicability of different scoring systems in outcome prediction of patients with mixed drug poisoning-induced coma. <italic toggle="yes">Indian J. Anaesth.</italic><bold>55</bold>(6), 599&#8211;604 (2011).<pub-id pub-id-type="pmid">22223905</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0019-5049.90616</pub-id><pub-id pub-id-type="pmcid">PMC3249868</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liisanantti</surname><given-names>JH</given-names></name><name name-style="western"><surname>Ohtonen</surname><given-names>P</given-names></name><name name-style="western"><surname>Kiviniemi</surname><given-names>O</given-names></name><name name-style="western"><surname>Laurila</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Ala-Kokko</surname><given-names>TI</given-names></name></person-group><article-title>Risk factors for prolonged intensive care unit stay and hospital mortality in acute drug-poisoned patients: an evaluation of the physiologic and laboratory parameters on admission</article-title><source>J. Crit. Care</source><year>2011</year><volume>26</volume><issue>2</issue><fpage>160</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.jcrc.2010.08.009</pub-id><pub-id pub-id-type="pmid">21036534</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Liisanantti, J. H., Ohtonen, P., Kiviniemi, O., Laurila, J. J. &amp; Ala-Kokko, T. I. Risk factors for prolonged intensive care unit stay and hospital mortality in acute drug-poisoned patients: an evaluation of the physiologic and laboratory parameters on admission. <italic toggle="yes">J. Crit. Care</italic>. <bold>26</bold>(2), 160&#8211;165 (2011).<pub-id pub-id-type="pmid">21036534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcrc.2010.08.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dillinger</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Prognostic value of plasma B-type natriuretic peptide in patients with severe cardiotoxic drug poisoning</article-title><source>Acute Card Care</source><year>2011</year><volume>13</volume><issue>3</issue><fpage>174</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.3109/17482941.2011.606472</pub-id><pub-id pub-id-type="pmid">21877877</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Dillinger, J. G. et al. Prognostic value of plasma B-type natriuretic peptide in patients with severe cardiotoxic drug poisoning. <italic toggle="yes">Acute Card Care</italic><bold>13</bold>(3), 174&#8211;180 (2011).<pub-id pub-id-type="pmid">21877877</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17482941.2011.606472</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maignan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Deliberate drug poisoning with slight symptoms on admission: are there predictive factors for intensive care unit referral? A three-year retrospective study</article-title><source>Basic. Clin. Pharmacol. Toxicol.</source><year>2014</year><volume>114</volume><issue>3</issue><fpage>281</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1111/bcpt.12132</pub-id><pub-id pub-id-type="pmid">23998644</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Maignan, M. et al. Deliberate drug poisoning with slight symptoms on admission: are there predictive factors for intensive care unit referral? A three-year retrospective study. <italic toggle="yes">Basic. Clin. Pharmacol. Toxicol.</italic><bold>114</bold>(3), 281&#8211;287 (2014).<pub-id pub-id-type="pmid">23998644</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/bcpt.12132</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Athavale</surname><given-names>V</given-names></name><name name-style="western"><surname>Green</surname><given-names>C</given-names></name><name name-style="western"><surname>Lim</surname><given-names>KZ</given-names></name><name name-style="western"><surname>Wong</surname><given-names>C</given-names></name><name name-style="western"><surname>Tiruvoipati</surname><given-names>R</given-names></name></person-group><article-title>Characteristics and outcomes of patients with drug overdose requiring admission to Intensive Care Unit</article-title><source>Australas Psychiatry</source><year>2017</year><volume>25</volume><issue>5</issue><fpage>489</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1177/1039856217706824</pub-id><pub-id pub-id-type="pmid">28703691</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Athavale, V., Green, C., Lim, K. Z., Wong, C. &amp; Tiruvoipati, R. Characteristics and outcomes of patients with drug overdose requiring admission to Intensive Care Unit. <italic toggle="yes">Australas. Psychiatry</italic><bold>25</bold>(5), 489&#8211;493 (2017).<pub-id pub-id-type="pmid">28703691</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1039856217706824</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cioccari</surname><given-names>L</given-names></name><name name-style="western"><surname>Luethi</surname><given-names>N</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>M</given-names></name><name name-style="western"><surname>Pilcher</surname><given-names>D</given-names></name><name name-style="western"><surname>Bellomo</surname><given-names>R</given-names></name></person-group><article-title>Characteristics and outcomes of critically ill patients with drug overdose in Australia and New Zealand</article-title><source>Crit. Care Resusc.</source><year>2017</year><volume>19</volume><issue>1</issue><fpage>14</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">28215127</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Cioccari, L., Luethi, N., Bailey, M., Pilcher, D. &amp; Bellomo, R. Characteristics and outcomes of critically ill patients with drug overdose in Australia and New Zealand. <italic toggle="yes">Crit. Care Resusc.</italic><bold>19</bold>(1), 14&#8211;22 (2017).<pub-id pub-id-type="pmid">28215127</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghasemi</surname><given-names>M</given-names></name><name name-style="western"><surname>Yaraghi</surname><given-names>A</given-names></name><name name-style="western"><surname>Farajzadegan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sabzghabaee</surname><given-names>AM</given-names></name><name name-style="western"><surname>Eizadi-Mood</surname><given-names>N</given-names></name></person-group><article-title>What are the predictive factors for the treatment outcomes in Multi Drug Poisoning including Antidepressants/Antipsychotic drugs?</article-title><source>Adv. Biomed. Res.</source><year>2018</year><volume>7</volume><fpage>136</fpage><pub-id pub-id-type="doi">10.4103/abr.abr_132_18</pub-id><pub-id pub-id-type="pmid">30464936</pub-id><pub-id pub-id-type="pmcid">PMC6206742</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Ghasemi, M., Yaraghi, A., Farajzadegan, Z., Sabzghabaee, A. M. &amp; Eizadi-Mood, N. What are the predictive factors for the treatment outcomes in multi drug poisoning including antidepressants/antipsychotic drugs? <italic toggle="yes">Adv. Biomed. Res.</italic><bold>7</bold>, 136 (2018).<pub-id pub-id-type="pmid">30464936</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/abr.abr_132_18</pub-id><pub-id pub-id-type="pmcid">PMC6206742</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savage</surname><given-names>M</given-names></name><etal/></person-group><article-title>Predictors of ICU admission and long-term outcomes in overdose presentations to Emergency Department</article-title><source>Australas Psychiatry</source><year>2020</year><volume>28</volume><issue>1</issue><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1177/1039856219889317</pub-id><pub-id pub-id-type="pmid">31912753</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Savage, M. et al. Predictors of ICU admission and long-term outcomes in overdose presentations to emergency department. <italic toggle="yes">Australas. Psychiatry</italic><bold>28</bold>(1), 75&#8211;79 (2020).<pub-id pub-id-type="pmid">31912753</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1039856219889317</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Gharbawy</surname><given-names>DM</given-names></name><name name-style="western"><surname>Kabbash</surname><given-names>IA</given-names></name><name name-style="western"><surname>Ghonem</surname><given-names>MM</given-names></name></person-group><article-title>A nomogram proposal for early prediction of intensive care unit admission in patients with acute antipsychotic poisoning</article-title><source>Toxicol. Res. (Camb)</source><year>2023</year><volume>12</volume><issue>5</issue><fpage>873</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1093/toxres/tfad078</pub-id><pub-id pub-id-type="pmid">37915484</pub-id><pub-id pub-id-type="pmcid">PMC10615807</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">El-Gharbawy, D. M., Kabbash, I. A. &amp; Ghonem, M. M. A nomogram proposal for early prediction of intensive care unit admission in patients with acute antipsychotic poisoning. <italic toggle="yes">Toxicol. Res. (Camb)</italic>. <bold>12</bold>(5), 873&#8211;883 (2023).<pub-id pub-id-type="pmid">37915484</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxres/tfad078</pub-id><pub-id pub-id-type="pmcid">PMC10615807</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engin</surname><given-names>E</given-names></name><name name-style="western"><surname>Benham</surname><given-names>RS</given-names></name><name name-style="western"><surname>Rudolph</surname><given-names>U</given-names></name></person-group><article-title>An Emerging Circuit Pharmacology of GABAA receptors</article-title><source>Trends Pharmacol. Sci.</source><year>2018</year><volume>39</volume><issue>8</issue><fpage>710</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2018.04.003</pub-id><pub-id pub-id-type="pmid">29903580</pub-id><pub-id pub-id-type="pmcid">PMC6056379</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Engin, E., Benham, R. S. &amp; Rudolph, U. An emerging circuit pharmacology of GABAA receptors. <italic toggle="yes">Trends Pharmacol. Sci.</italic><bold>39</bold>(8), 710&#8211;732 (2018).<pub-id pub-id-type="pmid">29903580</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tips.2018.04.003</pub-id><pub-id pub-id-type="pmcid">PMC6056379</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghit</surname><given-names>A</given-names></name><name name-style="western"><surname>Assal</surname><given-names>D</given-names></name><name name-style="western"><surname>Al-Shami</surname><given-names>AS</given-names></name><name name-style="western"><surname>Hussein</surname><given-names>DEE</given-names></name></person-group><article-title>GABAA receptors: structure, function, pharmacology, and related disorders</article-title><source>J. Genet. Eng. Biotechnol.</source><year>2021</year><volume>19</volume><issue>1</issue><fpage>123</fpage><pub-id pub-id-type="doi">10.1186/s43141-021-00224-0</pub-id><pub-id pub-id-type="pmid">34417930</pub-id><pub-id pub-id-type="pmcid">PMC8380214</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Ghit, A., Assal, D., Al-Shami, A. S. &amp; Hussein, D. E. E. GABAA receptors: structure, function, pharmacology, and related disorders. <italic toggle="yes">J. Genet. Eng. Biotechnol.</italic><bold>19</bold>(1), 123 (2021).<pub-id pub-id-type="pmid">34417930</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s43141-021-00224-0</pub-id><pub-id pub-id-type="pmcid">PMC8380214</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ong</surname><given-names>J</given-names></name><name name-style="western"><surname>Kerr</surname><given-names>DI</given-names></name></person-group><article-title>Clinical potential of GABAB receptor modulators</article-title><source>CNS Drug Rev.</source><year>2005</year><volume>11</volume><issue>3</issue><fpage>317</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1111/j.1527-3458.2005.tb00049.x</pub-id><pub-id pub-id-type="pmid">16389296</pub-id><pub-id pub-id-type="pmcid">PMC6741760</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Ong, J. &amp; Kerr, D. I. Clinical potential of GABAB receptor modulators. <italic toggle="yes">CNS Drug Rev.</italic><bold>11</bold>(3), 317&#8211;334 (2005).<pub-id pub-id-type="pmid">16389296</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1527-3458.2005.tb00049.x</pub-id><pub-id pub-id-type="pmcid">PMC6741760</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Enz</surname><given-names>R</given-names></name></person-group><article-title>GABA(C) receptors: a molecular view</article-title><source>Biol. Chem.</source><year>2001</year><volume>382</volume><issue>8</issue><fpage>1111</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1515/BC.2001.141</pub-id><pub-id pub-id-type="pmid">11592392</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Enz, R. GABA(C) receptors: a molecular view. <italic toggle="yes">Biol. Chem.</italic><bold>382</bold>(8), 1111&#8211;1122 (2001).<pub-id pub-id-type="pmid">11592392</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/BC.2001.141</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><etal/></person-group><article-title>mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists</article-title><source>Science</source><year>2010</year><volume>329</volume><issue>5994</issue><fpage>959</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1126/science.1190287</pub-id><pub-id pub-id-type="pmid">20724638</pub-id><pub-id pub-id-type="pmcid">PMC3116441</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Li, N. et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. <italic toggle="yes">Science</italic><bold>329</bold>(5994), 959&#8211;964 (2010).<pub-id pub-id-type="pmid">20724638</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1190287</pub-id><pub-id pub-id-type="pmcid">PMC3116441</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawn</surname><given-names>T</given-names></name><etal/></person-group><article-title>Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD</article-title><source>Psychopharmacol. (Berl)</source><year>2022</year><volume>239</volume><issue>6</issue><fpage>1797</fpage><lpage>1808</lpage><pub-id pub-id-type="doi">10.1007/s00213-022-06117-5</pub-id><pub-id pub-id-type="pmcid">PMC9166846</pub-id><pub-id pub-id-type="pmid">35322297</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Lawn, T. et al. Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD. <italic toggle="yes">Psychopharmacol. (Berl)</italic>. <bold>239</bold>(6), 1797&#8211;1808 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00213-022-06117-5</pub-id><pub-id pub-id-type="pmcid">PMC9166846</pub-id><pub-id pub-id-type="pmid">35322297</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shine</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Human cognition involves the dynamic integration of neural activity and neuromodulatory systems [published correction appears in</article-title><source>Nat. Neurosci.</source><year>2019</year><volume>22</volume><issue>6</issue><fpage>1036</fpage><pub-id pub-id-type="doi">10.1038/s41593-019-0347-x</pub-id><pub-id pub-id-type="pmid">30792538</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Shine, J. M. et al. Human cognition involves the dynamic integration of neural activity and neuromodulatory systems [published correction appears in. <italic toggle="yes">Nat. Neurosci.</italic><bold>22</bold>(6), 1036 (2019).<pub-id pub-id-type="pmid">30792538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41593-019-0347-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adrogu&#233;</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Madias</surname><given-names>NE</given-names></name></person-group><article-title>Management of life-threatening acid-base disorders. Second of two parts</article-title><source>N Engl. J. Med.</source><year>1998</year><volume>338</volume><issue>2</issue><fpage>107</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1056/NEJM199801083380207</pub-id><pub-id pub-id-type="pmid">9420343</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Adrogu&#233;, H. J. &amp; Madias, N. E. Management of life-threatening acid-base disorders. Second of two parts. <italic toggle="yes">N Engl. J. Med.</italic><bold>338</bold>(2), 107&#8211;111 (1998).<pub-id pub-id-type="pmid">9420343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJM199801083380207</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sahu</surname><given-names>A</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>HA</given-names></name><name name-style="western"><surname>Panza</surname><given-names>JA</given-names></name></person-group><article-title>The initial anion gap is a predictor of mortality in acute myocardial infarction</article-title><source>Coron. Artery Dis.</source><year>2006</year><volume>17</volume><issue>5</issue><fpage>409</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1097/00019501-200608000-00002</pub-id><pub-id pub-id-type="pmid">16845247</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Sahu, A., Cooper, H. A. &amp; Panza, J. A. The initial anion gap is a predictor of mortality in acute myocardial infarction. <italic toggle="yes">Coron. Artery Dis.</italic><bold>17</bold>(5), 409&#8211;412 (2006).<pub-id pub-id-type="pmid">16845247</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00019501-200608000-00002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lolekha</surname><given-names>PH</given-names></name><name name-style="western"><surname>Vanavanan</surname><given-names>S</given-names></name><name name-style="western"><surname>Lolekha</surname><given-names>S</given-names></name></person-group><article-title>Update on value of the anion gap in clinical diagnosis and laboratory evaluation</article-title><source>Clin. Chim. Acta</source><year>2001</year><volume>307</volume><issue>1&#8211;2</issue><fpage>33</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/S0009-8981(01)00459-4</pub-id><pub-id pub-id-type="pmid">11369334</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Lolekha, P. H., Vanavanan, S. &amp; Lolekha, S. Update on value of the anion gap in clinical diagnosis and laboratory evaluation. <italic toggle="yes">Clin. Chim. Acta</italic><bold>307</bold>(1&#8211;2), 33&#8211;36 (2001).<pub-id pub-id-type="pmid">11369334</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0009-8981(01)00459-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thuan</surname><given-names>L</given-names></name><etal/></person-group><article-title>Effectiveness of continuous veno-venous hemofiltration and intermittent hemodialysis in the treatment of severe Acute Phenobarbital Poisoning</article-title><source>Asia Pac. J. Med. Toxicol.</source><year>2013</year><volume>2</volume><fpage>10</fpage><lpage>13</lpage></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Thuan, L. et al. Effectiveness of continuous veno-venous hemofiltration and intermittent hemodialysis in the treatment of severe Acute Phenobarbital Poisoning. <italic toggle="yes">Asia Pac. J. Med. Toxicol.</italic><bold>2</bold>, 10&#8211;13 (2013).</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mactier</surname><given-names>R</given-names></name><etal/></person-group><article-title>EXTRIP Workgroup. Extracorporeal treatment for barbiturate poisoning: recommendations from the EXTRIP Workgroup</article-title><source>Am. J. Kidney Dis.</source><year>2014</year><volume>64</volume><issue>3</issue><fpage>347</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2014.04.031</pub-id><pub-id pub-id-type="pmid">24998037</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Mactier, R. et al. EXTRIP Workgroup. Extracorporeal treatment for barbiturate poisoning: recommendations from the EXTRIP Workgroup. <italic toggle="yes">Am. J. Kidney Dis.</italic><bold>64</bold>(3), 347&#8211;358 (2014).<pub-id pub-id-type="pmid">24998037</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.ajkd.2014.04.031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>DM</given-names></name><name name-style="western"><surname>Buckley</surname><given-names>NA</given-names></name></person-group><article-title>Enhanced elimination in acute barbiturate poisoning - a systematic review</article-title><source>Clin. Toxicol. (Phila)</source><year>2011</year><volume>49</volume><issue>1</issue><fpage>2</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.3109/15563650.2010.550582</pub-id><pub-id pub-id-type="pmid">21288146</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Roberts, D. M. &amp; Buckley, N. A. Enhanced elimination in acute barbiturate poisoning - a systematic review. <italic toggle="yes">Clin. Toxicol. (Phila)</italic><bold>49</bold>(1), 2&#8211;12 (2011).<pub-id pub-id-type="pmid">21288146</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/15563650.2010.550582</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hori</surname><given-names>S</given-names></name><name name-style="western"><surname>Kinoshita</surname><given-names>K</given-names></name></person-group><article-title>Clinical characteristics of patients who overdose on multiple psychotropic drugs in Tokyo</article-title><source>J. Toxicol. Sci.</source><year>2016</year><volume>41</volume><issue>6</issue><fpage>765</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.2131/jts.41.765</pub-id><pub-id pub-id-type="pmid">27853105</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Hori, S. &amp; Kinoshita, K. Clinical characteristics of patients who overdose on multiple psychotropic drugs in Tokyo. <italic toggle="yes">J. Toxicol. Sci.</italic><bold>41</bold>(6), 765&#8211;773 (2016).<pub-id pub-id-type="pmid">27853105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2131/jts.41.765</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Setter</surname><given-names>JG</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>RB</given-names></name><name name-style="western"><surname>Maher</surname><given-names>JF</given-names></name><name name-style="western"><surname>Schreiner</surname><given-names>GE</given-names></name></person-group><article-title>Factors influencing the dialysis of barbiturates</article-title><source>Trans. Am. Soc. Artif. Intern. Organs</source><year>1964</year><volume>10</volume><fpage>340</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">5878438</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Setter, J. G., Freeman, R. B., Maher, J. F. &amp; Schreiner, G. E. Factors influencing the dialysis of barbiturates. <italic toggle="yes">Trans. Am. Soc. Artif. Intern. Organs</italic><bold>10</bold>, 340&#8211;344 (1964).<pub-id pub-id-type="pmid">5878438</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>